Amgen Ventures

Corporate VC Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$14.0M
total disclosed, rounds participated
Stages
—

Portfolio · 2

Olive Diagnostics
Passive Sensor for Urinalysis
1 round $4.0M committed Latest: 2022-09
Gamida Cell
Cellular and Immune Therapies
1 round $10.0M committed Latest: 2012-05

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Amgen Ventures' primary investment focus?
Amgen Ventures primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.
Can you name some of Amgen Ventures' portfolio companies?
Amgen Ventures has invested in companies such as Gamida Cell, which specializes in Cellular and Immune Therapies, and Olive Diagnostics, which develops passive sensors for urinalysis.
What is Amgen Ventures' most recent investment activity?
Amgen Ventures made an investment in September 2022, which was a Seed round.
Has Amgen Ventures had any notable exits?
Yes, Amgen Ventures had an exit in October 2018 with Gamida Cell, which went public on NASDAQ with a valuation of $210M.
What is the typical investment stage for Amgen Ventures?
Amgen Ventures has participated in both Seed and E Round funding stages.
What is the total amount raised by Amgen Ventures' portfolio company, Gamida Cell?
Gamida Cell, a portfolio company of Amgen Ventures, has raised a total of $416.22M.
When was Amgen Ventures founded?
Amgen Ventures was founded in 2019.